日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Clinical Outcomes and Treatment Patterns in Advanced/Metastatic EGFR-Mutant NSCLC After Progression on First-Line Osimertinib for French Patients

法国患者一线奥希替尼治疗进展后,晚期/转移性EGFR突变型非小细胞肺癌的真实世界临床结果和治疗模式

Girard, Nicolas; Macouillard, Pauline; Byng, Danalyn; Meng, Jie; Coerts, Friso; Hunter, Shannon; Struebing, Alessandria; Xiong, Yan; Park, Sarah; Haq, M Inaam; Tymejczyk, Olga; Chouaid, Christos; Audigier-Valette, Clarisse; Debieuvre, Didier; Quantin, Xavier; Bosquet, Lise; Pérol, Maurice

Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer

EVIDENS 研究的最终 3 年结果,这是一项关于纳武利尤单抗治疗非小细胞肺癌的观察性研究

Barlesi, Fabrice; Dixmier, Adrien; Debieuvre, Didier; Raspaud, Christophe; Auliac, Jean-Bernard; Benoit, Nicolas; Bombaron, Pierre; Moro-Sibilot, Denis; Asselain, Bernard; Audigier-Valette, Clarisse; Brellier, Florence; Cotté, François-Emery; Khalife, Yaacoub; Pérol, Maurice

Surrogate markers of intestinal dysfunction associated with survival in advanced cancers

与晚期癌症患者生存相关的肠道功能障碍替代标志物

Birebent, Roxanne; Drubay, Damien; Alves Costa Silva, Carolina; Marmorino, Federica; Vitali, Giacomo; Piccinno, Gianmarco; Hurtado, Yoan; Bonato, Adele; Belluomini, Lorenzo; Messaoudene, Meriem; Routy, Bertrand; Fidelle, Marine; Zalcman, Gerard; Mazieres, Julien; Audigier-Valette, Clarisse; Moro-Sibilot, Denis; Goldwasser, François; Scherpereel, Arnaud; Pegliasco, Hervé; Ghiringhelli, François; Reni, Anna; Barlesi, Fabrice; Albiges, Laurence; Planchard, David; Martinez, Stéphanie; Besse, Benjamin; Segata, Nicola; Cremolini, Chiara; Zitvogel, Laurence; Iebba, Valerio; Derosa, Lisa

MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial

在IFCT-0701 MAPS 3期试验中,miR-193b-3p和miR-132-3p作为接受一线贝伐单抗联合培美曲塞-铂类化疗的胸膜间皮瘤患者生存预后生物标志物。

Levallet, Guénaëlle; Creveuil, Christian; Léger-Vigot, Alexandre; Brosseau, Solenn; Danel, Claire; Scherpereel, Arnaud; Lantuejoul, Sylvie; Mazières, Julien; Greillier, Laurent; Audigier-Valette, Clarisse; Bergot, Emmanuel; Moro-Sibilot, Denis; Molinier, Olivier; Léna, Hervé; Monnet, Isabelle; Morin, Franck; Gounant, Valérie; Zalcman, Gérard

Compassionate Access to Brigatinib for Patients with Non-small-cell Lung Cancer Harboring a ROS1 Rearrangement: Results from the BRIGAROS Study

为携带 ROS1 重排的非小细胞肺癌患者提供 Brigatinib 的同情用药:BRIGAROS 研究的结果

Mourlanette, Jean; Rousseau-Bussac, Gaelle; Mallah, Siham; Guisier, Florian; Zalcman, Gerard; Veillon, Rémi; Audigier-Valette, Clarisse; Roa, Magali; Nicolle, Isabelle; Doubre, Helene; Cloarec, Nicolas; Lamy, Régine; Morel, Hugues; Curcio, Hubert; Lagrange, Aurélie; Schott, Roland; Sabatini, Marielle; Toffart, Anne Claire; Pinsolle, Julian; Bennouna, Jaafar; Chouaid, Christos; Mazieres, Julien

Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis

法国接受纳武利尤单抗二线或后续治疗的晚期或转移性非小细胞肺癌患者的真实世界治疗和再治疗模式及结局:一项IO Optimise分析

Justeau, Grégoire; Chouaid, Christos; Debieuvre, Didier; Audigier-Valette, Clarisse; Quantin, Xavier; Léna, Hervé; Bosquet, Lise; Girard, Nicolas; Schoemaker, Minouk J; Mella, Marta; Pinto Correia, Bárbara; Rault, Caroline; Daumont, Melinda J; Penrod, John R; Lee, Adam; Pérol, Maurice

Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort

根据KRAS突变状态分析法国真实世界ESME队列中晚期NSCLC患者的临床特征和生存结果

Thomas, Q D; Quantin, X; Lemercier, P; Chouaid, C; Schneider, S; Filleron, T; Remon-Masip, J; Perol, M; Debieuvre, D; Audigier-Valette, C; Justeau, G; Loeb, A; Hiret, S; Clement-Duchene, C; Dansin, E; Stancu, A; Pichon, E; Bosquet, L; Girard, N; Du Rusquec, P

Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study

Luribinectedin治疗广泛期小细胞肺癌:IFCT-2105 LURBICLIN研究简报

Girard, N; Guisier, F; Swalduz, A; Van Hulst, S; Pichon, E; Lavaud, P; Greillier, L; Tiotiu, A; Madroszyk, A; Bylicki, O; Canellas, A; Belmont, L; Zysman, M; Hauss, P-A; Godbert, B; Audigier-Valette, C; Lebreton, C; Morin, F; Westeel, V

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227

CheckMate 227 研究比较了纳武利尤单抗联合伊匹木单抗与化疗作为转移性非小细胞肺癌一线治疗方案的五年生存结果。

Brahmer, Julie R; Lee, Jong-Seok; Ciuleanu, Tudor-Eliade; Bernabe Caro, Reyes; Nishio, Makoto; Urban, Laszlo; Audigier-Valette, Clarisse; Lupinacci, Lorena; Sangha, Randeep; Pluzanski, Adam; Burgers, Jacobus; Mahave, Mauricio; Ahmed, Samreen; Schoenfeld, Adam J; Paz-Ares, Luis G; Reck, Martin; Borghaei, Hossein; O'Byrne, Kenneth J; Gupta, Ravi G; Bushong, Judith; Li, Li; Blum, Steven I; Eccles, Laura J; Ramalingam, Suresh S

First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

一线纳武利尤单抗联合伊匹木单抗治疗转移性非小细胞肺癌,包括ECOG体能状态评分为2的患者和其他特殊人群:CheckMate 817

Ready, Neal E; Audigier-Valette, Clarisse; Goldman, Jonathan W; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Rosario García Campelo, María; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stéphanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sébastien; Zannori, Cristina; Vermaelen, Karim; Arén Frontera, Osvaldo; Curioni Fontecedro, Alessandra; Sánchez-Gastaldo, Amparo; Juan-Vidal, Oscar; Linardou, Helena; Poddubskaya, Elena; Spigel, David R; Ahmed, Samreen; Maio, Michele; Li, Sunney; Chang, Han; Fiore, Joseph; Acevedo, Angelic; Paz-Ares, Luis